"Cardiology practice"

During the past decade, Florida Cardiovascular Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Cardiovascular Research" #1 sponsor was "Alexion" with 1 trials, followed by "Anesiva, Inc." with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Florida Atlantic University" with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cardiovascular Research" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cardialysis BV" with 1 trials as a collaborator and "Sanofi-Synthelabo" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Florida Cardiovascular Research" are "Coronary Artery Disease" (2 trials), "Angioplasty, Transluminal, Percutaneous Coronary" (1 trials), "Atherosclerosis" (1 trials), "Cardio-pulmonary Bypass" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "Florida Cardiovascular Research" in a lesser frequency.

Most popular intervention types in "Florida Cardiovascular Research" are "Drug" (6 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (2 trials), "CGT003 (E2F Duplex Decoy)" (1 trials), "Clopidogrel 75" (1 trials), "Coronary Artery Bypass Surgery" (1 trials) and "Otamixaban (XRP0673)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cardiovascular Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Florida Cardiovascular Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Florida Cardiovascular Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cardiovascular Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".